Lunai Bioworks Inc. Conversion of Stock, Shares Converted
Lunai Bioworks Inc. (LNAI) reported Conversion of Stock, Shares Converted of 4.58 thousand shares for the 1-month period ending 2025-12-29, per its 10-Q filed 2026-02-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-02-17
- 2025-12-29: Conversion of Stock, Shares Converted 1 month 4.58K shares.
- 2023-08-01: Conversion of Stock, Shares Converted 0 month 280.50K shares.
| Period end | Conversion of Stock, Shares Converted 0 month | Conversion of Stock, Shares Converted 1 month |
|---|---|---|
| 2025-12-29 | 4.58K shares 10-Q · filed 2026-02-17 | |
| 2023-08-01 | 280.50K shares 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |